Patients with prostate cancer (PC) with clinically positive lymph nodes detectable via conventional imaging have always been perceived as a challenge, especially with regard to the value of applying local treatment. Over the years, many of these patients have been treated with androgen deprivation therapy (ADT) only. Studies in this specific setting are scarce and mostly retrospective. This issue of European Urology Oncology contains a systematic review of the role of local treatments in this patient population by Ventimiglia et al
Introduction: Approximately 50% of men diagnosed with prostate cancer will be exposed to androgen de...
Item does not contain fulltextPURPOSE: To determine the oncologic benefit or otherwise of local trea...
PURPOSE OF REVIEW: To investigate the features and optimal management of pN+ cM0 prostate cancer (PC...
Pelvic lymph node involvement in prostate cancer is a significant poor prognostic factor with very l...
BACKGROUND: There is limited evidence supporting the use of local treatment (LT) for prostate cancer...
Although widespread PSA screening has inevitably led to increased diagnosis of lower risk prostate c...
Context: There is uncertainty regarding the oncologic effectiveness and the survival advantage of lo...
Context: Androgen-deprivation therapy (ADT) plays a pivotal role in the management of locally advanc...
CONTEXT There is uncertainty regarding the oncologic effectiveness and the survival advantage of ...
The role of local treatment (with surgery or radiation [RT]) for patients with lymph node–positive M...
To investigate the features and optimal management of pN+ cM0 prostate cancer (PCa) according to reg...
To provide an overview of the currently available literature regarding local control of primary tumo...
Introduction: A considerable proportion of patients are still found with nodal involvement when cons...
To provide an overview of the currently available literature regarding local control of primary tumo...
Copyright © 2014 Fouad Aoun et al. This is an open access article distributed under the Creative Com...
Introduction: Approximately 50% of men diagnosed with prostate cancer will be exposed to androgen de...
Item does not contain fulltextPURPOSE: To determine the oncologic benefit or otherwise of local trea...
PURPOSE OF REVIEW: To investigate the features and optimal management of pN+ cM0 prostate cancer (PC...
Pelvic lymph node involvement in prostate cancer is a significant poor prognostic factor with very l...
BACKGROUND: There is limited evidence supporting the use of local treatment (LT) for prostate cancer...
Although widespread PSA screening has inevitably led to increased diagnosis of lower risk prostate c...
Context: There is uncertainty regarding the oncologic effectiveness and the survival advantage of lo...
Context: Androgen-deprivation therapy (ADT) plays a pivotal role in the management of locally advanc...
CONTEXT There is uncertainty regarding the oncologic effectiveness and the survival advantage of ...
The role of local treatment (with surgery or radiation [RT]) for patients with lymph node–positive M...
To investigate the features and optimal management of pN+ cM0 prostate cancer (PCa) according to reg...
To provide an overview of the currently available literature regarding local control of primary tumo...
Introduction: A considerable proportion of patients are still found with nodal involvement when cons...
To provide an overview of the currently available literature regarding local control of primary tumo...
Copyright © 2014 Fouad Aoun et al. This is an open access article distributed under the Creative Com...
Introduction: Approximately 50% of men diagnosed with prostate cancer will be exposed to androgen de...
Item does not contain fulltextPURPOSE: To determine the oncologic benefit or otherwise of local trea...
PURPOSE OF REVIEW: To investigate the features and optimal management of pN+ cM0 prostate cancer (PC...